Showing results (401-410 of 588) with videos related to
Sort By:
Pageof 59
Molecular Cancer Research : MCR|August 5, 2025
Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate CancerSinead Flanagan, Rosina T Lis, Ying Huang, et al.Plos One|August 2, 2014
Identification of ALK gene alterations in urothelial carcinomaJoaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.Biorxiv : the Preprint Server for Biology|March 11, 2024
Canonical AREs are tumor suppressive regulatory elements in the prostateMichael A Augello, Xuanrong Chen, Deli Liu, et al.Iscience|February 8, 2024
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse modelYufei Wang, Jae-Won Cho, Gabriella Kastrunes, et al.Science Translational Medicine|July 14, 2017
HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferaseAbhishek A Chakraborty, Eijiro Nakamura, Jun Qi, et al.Cancer Cell|August 14, 2014
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressorGang Lu, Qing Zhang, Ying Huang, et al.Cancer Discovery|February 6, 2015
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and TumorigenesisAndrea Lunardi, Shohreh Varmeh, Ming Chen, et al.Plos Genetics|August 6, 2016
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma DevelopmentKrinio Giannikou, Izabela A Malinowska, Trevor J Pugh, et al.Oncotarget|May 5, 2016
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulationJianmin Wang, Antonios Papanicolau-Sengos, Sreenivasulu Chintala, et al.Pageof 59